Clinical Nutrition Market - By Product (Infant Nutrition, Enteral Nutrition, Parenteral Nutrition), By Consumer (Pediatric, Adult), By Application (Cancer, Metabolic Disorders, Neurological Diseases), By Distribution Channel, By Dosage Formulation & Forecast, 2023-2032

Clinical Nutrition Market - By Product (Infant Nutrition, Enteral Nutrition, Parenteral Nutrition), By Consumer (Pediatric, Adult), By Application (Cancer, Metabolic Disorders, Neurological Diseases), By Distribution Channel, By Dosage Formulation & Forecast, 2023-2032

Clinical Nutrition Market Size

Clinical Nutrition Market size was valued at over USD 50.5 billion in 2022. Driven by the growing occurrence of metabolic disorders and numerous other chronic conditions worldwide, the market is expected to grow at over 10% CAGR from 2023 to 2032. 
 

Surging prevalence of chronic conditions such as respiratory diseases, cardiovascular ailments, cancer, gastrointestinal disorders, and malnourishment among adults and children is elevating the need for nutritional support. Oropharyngeal dysphagia, while commonly observed among the geriatric population, is often also reported in patients suffering from neurological diseases such as multiple sclerosis, oropharyngeal dysphagia, Parkinson's disease, and dementia.
 

The swallowing problems caused by the condition are creating a strong impetus for clinical nutrition, especially as the disease load of neurological disorders continues to rise across the globe. As per a report published by WHO in 2022, the number of people suffering from dementia is likely to reach 78 million in 2030 and 139 million in 2050.
 

Strict regulatory scenario may dampen the clinical nutrition market outlook

Strict regulations governing the clinical nutrition landscape may hold back the industry scenario through 2032. In the US, the FDA regulates clinical nutrition products under a different set of guidelines than those covering drug products and conventional food items. Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), the FDA prohibits the sale of clinical nutrition products that are misbranded of adulterated in any way.
 

With patient lives on the line, manufacturers have to strictly adhere to the regulatory guidelines, and any type of alterations to the product compositions have to get approved by the governing body before commercialization can be commenced. This makes the cost of entry particularly high for newcomers in the sector.
 

Clinical Nutrition Market Analysis

Based on product, the clinical nutrition market size from enteral nutrition segment was valued at more than USD 17.1 billion in 2022. Increasing cases of pediatric gastrointestinal disorders across the globe are likely to outline the market scenario. Enteral nutrition is usually prescribed to patients with partially functioning gut to effectively fulfil their energy as well as nutrient requirements. Often people with gastrointestinal disorders are not able to meet their day-to-day nutrition requirements through regular food intake, making enteral feeding integral for their health. This type of clinical nutrition is efficacious in most cases of GI disorders due to its ability to deliver enhanced patient outcomes without many complications.
 

Based on consumer, clinical nutrition market from the pediatric consumer segment is slated to surpass USD 78.2 billion by 2032, driven by the surging prevalence of poverty and overpopulation in underdeveloped nations. Poverty and overpopulation is an unfortunate mix that often leads to malnourishment among children. As per the World Bank, more than 10 million people, approximately 41.8% of the population fell under the extreme poverty line in Niger, an underdeveloped West African country, in 2021.